
Medistim ASA
OSE:MEDI

Operating Margin
Medistim ASA
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
NO |
![]() |
Medistim ASA
OSE:MEDI
|
3.9B NOK |
23%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
234.1B USD |
17%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
198.1B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
156.7B USD |
19%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
148.8B USD |
22%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
110.8B USD |
19%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
55B EUR |
14%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD |
13%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.8B USD |
28%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.7B USD |
29%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
271.2B CNY |
34%
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Medistim ASA's most recent financial statements, the company has Operating Margin of 23.3%.